Related Experiment Videos
The AIDS epidemic
1Department of Dermatology, University of California, San Francisco.
Abstract:
The nature of the clinical presentation of HIV infection continues to evolve over time. New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic (e.g., Aspergillus fumigatus and Penicillium marneffei) opportunistic fungal infections can now be added to the classic clinical markers for progressive HIV infection, such as Kaposi's sarcoma, Pneumocystis carinii pneumonia, Mycobacterium avium intercellulare infections, and cryptococcal meningitis. The fact that the appearance of many of these fungal diseases is directly correlated with the patient's CD4 cell count is a valuable tool for ongoing clinical evaluation. Although systemic manifestations characterize a progression from asymptomatic HIV infection to AIDS, many of the signs of disease progression are cutaneous. Prophylaxis against many of the potentially life-threatening systemic opportunistic infections associated with HIV positivity has had a positive impact on the life expectancy of patients with AIDS.
Insights
New fungal infections, both skin and systemic, are emerging clinical markers for progressive human immunodeficiency virus (HIV) infection. Monitoring these alongside CD4 cell counts aids in evaluating HIV progression and managing opportunistic infections.
Area of Science:
- Infectious Diseases
- Immunology
- Dermatology
Background:
- The clinical presentation of human immunodeficiency virus (HIV) infection is dynamic.
- Classic markers for progressive HIV infection include Kaposi's sarcoma, Pneumocystis carinii pneumonia, Mycobacterium avium intercellulare infections, and cryptococcal meningitis.
Purpose of the Study:
- To identify and categorize new opportunistic fungal infections associated with HIV.
- To highlight the correlation between fungal disease presentation and CD4 cell counts in HIV patients.
- To emphasize the role of cutaneous manifestations in assessing HIV disease progression.
Main Methods:
- Review of clinical presentations in evolving HIV infection.
- Identification of emerging cutaneous and systemic opportunistic fungal infections.
- Correlation analysis between fungal disease onset and CD4+ T-cell counts.
Main Results:
- New cutaneous fungal infections (seborrheic dermatitis, onychomycosis, tinea pedis) and systemic fungal infections (Aspergillus fumigatus, Penicillium marneffei) are now recognized.
- The incidence of many fungal infections correlates with declining CD4 cell counts.
- Cutaneous signs are significant indicators of HIV disease progression.
Conclusions:
- Emerging fungal infections provide valuable clinical markers for HIV progression.
- CD4 cell count monitoring alongside these fungal markers aids patient evaluation.
- Prophylaxis for opportunistic infections improves life expectancy in patients with acquired immunodeficiency syndrome (AIDS).